SEC to review Nasdaq bitcoin options approval after CME challenge
The SEC has frozen its approval of Nasdaq's bitcoin index options following a legal challenge from the CME Group. The CME argues that the SEC lacks jurisdiction over these products, claiming they should be regulated as commodities under the CFTC.
Why it matters
This regulatory dispute highlights the ongoing jurisdictional battle between the SEC and CFTC regarding the classification and oversight of crypto-based financial derivatives.
Back in May, the SEC granted Nasdaq PHLX conditional approval to list cash-settled bitcoin index options under the ticker QBTC. The product still required exemptions from the Commodity Futures Trading Commission (CFTC) before it could launch.
CME Group challenged the approval in June , arguing that bitcoin is a commodity and, as such, options tied directly to its value fall under the CFTC’s exclusive jurisdiction rather than the SEC’s.
If the CME is right, the SEC would have no authority to approve QBTC, and Nasdaq would need to register as a CFTC-regulated futures or swaps venue, or redesign the contracts to track a security such as a spot bitcoin exchange-traded fund.
The CME already operates regulated bitcoin futures and options markets, while Nasdaq’s QBTC would compete for the same trading activity without Nasdaq registering under the CFTC framework that governs the CME.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in